Free Trial

Allstate (ALL) Stock Forecast & Price Target

Allstate logo
$197.60 +2.55 (+1.30%)
As of 10:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Allstate - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
1
Buy
14

Based on 16 Wall Street analysts who have issued ratings for Allstate in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 1 has given a sell rating, 1 has given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for ALL.

Consensus Price Target

$217.94
10.29% Upside
According to the 16 analysts' twelve-month price targets for Allstate, the average price target is $217.94. The highest price target for ALL is $267.00, while the lowest price target for ALL is $183.00. The average price target represents a forecasted upside of 10.29% from the current price of $197.61.
Get the Latest News and Ratings for ALL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Allstate and its competitors.

Sign Up

ALL Analyst Ratings Over Time

TypeCurrent Forecast
2/29/24 to 2/28/25
1 Month Ago
1/30/24 to 1/29/25
3 Months Ago
12/1/23 to 11/30/24
1 Year Ago
3/1/23 to 2/29/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$217.94$218.13$217.19$159.12
Forecasted Upside10.29% Upside14.14% Upside4.72% Upside-0.25% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ALL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Allstate Stock vs. The Competition

TypeAllstateFinance CompaniesS&P 500
Consensus Rating Score
2.88
2.51
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside10.06% Upside27.41% Upside15.73% Upside
News Sentiment Rating
Positive News

See Recent ALL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/11/2025Keefe, Bruyette & Woods
5 of 5 stars
Meyer Shields
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$235.00 ➝ $240.00+27.73%
1/14/2025Wells Fargo & Company
4 of 5 stars
E. Greenspan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$186.00 ➝ $187.00+1.12%
1/8/2025Evercore ISI
2 of 5 stars
D. Motemaden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeIn-Line ➝ Outperform
1/6/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Scott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetUnderweight ➝ Underweight$187.00 ➝ $183.00-3.25%
11/26/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$206.00 ➝ $244.00+20.71%
11/15/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$209.00 ➝ $230.00+17.44%
11/8/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$231.00 ➝ $267.00+36.29%
11/7/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$220.00 ➝ $228.00+19.74%
11/4/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$216.00 ➝ $225.00+22.78%
10/18/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$216.00 ➝ $233.00+19.62%
10/18/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Zaremski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$205.00 ➝ $214.00+10.26%
10/10/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$205.00 ➝ $207.00+11.52%
10/4/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$205.00 ➝ $220.00+15.64%
9/3/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$193.00 ➝ $224.00+2,240,000,000.00%
8/14/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$200.00 ➝ $200.00+10.97%
3/28/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$158.00 ➝ $190.00+11.91%
10/20/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$135.00 ➝ $156.00+24.96%
4/3/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Klauber
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:47 AM ET.


Should I Buy Allstate Stock? ALL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, February 26, 2025. Please send any questions or comments about these Allstate pros and cons to contact@marketbeat.com.

Allstate
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in The Allstate Co.:

  • The Allstate Co. has received multiple upgrades from analysts, with firms like Evercore ISI and Morgan Stanley raising their target prices, indicating strong confidence in the company's growth potential.
  • Currently, the stock price is $185.51, which is down 1.9% recently, potentially offering a buying opportunity for investors looking for value.
  • 76.47% of The Allstate Co.'s stock is owned by institutional investors, suggesting strong backing and confidence from major financial entities.
  • Recent reports indicate a consensus rating of "Moderate Buy" among analysts, with a target price averaging $217.94, which could imply significant upside potential for investors.
  • The company has shown resilience with a market capitalization of $49.12 billion and a relatively low PE ratio of 10.92, indicating it may be undervalued compared to its earnings.

Allstate
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in The Allstate Co. for these reasons:

  • Despite recent upgrades, Barclays has set an "underweight" rating on the stock, which may indicate concerns about its future performance compared to the market.
  • The stock has experienced volatility, with a recent trading volume of 1,427,939 shares, which is below its average volume, suggesting potential liquidity issues.
  • The Allstate Co. has a quick ratio of 0.40 and a current ratio of 0.36, indicating potential challenges in meeting short-term liabilities, which could be a red flag for investors.
  • One analyst has rated the stock with a sell rating, which could reflect underlying concerns about the company's future profitability or market conditions.
  • The stock's beta of 0.52 suggests lower volatility compared to the market, which may not appeal to investors seeking high-growth opportunities.

ALL Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Allstate is $217.94, with a high forecast of $267.00 and a low forecast of $183.00.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allstate in the last year. There is currently 1 sell rating, 1 hold rating, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALL shares.

According to analysts, Allstate's stock has a predicted upside of 10.29% based on their 12-month stock forecasts.

Over the previous 90 days, Allstate's stock had 1 upgrade by analysts.

Allstate has been rated by research analysts at Barclays, Evercore ISI, Keefe, Bruyette & Woods, and Wells Fargo & Company in the past 90 days.

Analysts like Allstate more than other "finance" companies. The consensus rating score for Allstate is 2.88 while the average consensus rating score for "finance" companies is 2.51. Learn more on how ALL compares to other companies.


This page (NYSE:ALL) was last updated on 2/28/2025 by MarketBeat.com Staff
From Our Partners